Atossa Genetics Inc

Neoleukin Therapeutics, Inc. is a biotechnology company based in Seattle, WA, focused on innovative therapeutics targeting the immune system to treat cancers and autoimmune diseases. The company leverages its proprietary technology platform to develop novel protein-based therapeutics that aim to enhance immune responses and improve patient outcomes. In addition to its research initiatives, Neoleukin is dedicated to ensuring the integrity and security of its platforms, which is crucial in an industry where trust and reliability are paramount. With a commitment to cutting-edge science and patient-centered solutions, Neoleukin Therapeutics strives to make significant advancements in healthcare. Generated from the website

Immune Design is a biotechnology company based in Seattle, WA that focuses on developing novel immunotherapies for cancer treatment. The company's research and development efforts are centered around harnessing the power of the immune system to target and eliminate cancer cells. With a team of dedicated scientists and researchers, Immune Design is committed to advancing innovative approaches in the field of oncology. Through their cutting-edge technologies and strategic collaborations, the company aims to make a meaningful impact in the fight against cancer.Generated from their business information

Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the development of innovative cancer treatments. Through science and technology, the company strives to develop and commercialize products that address unmet medical needs, improve survival and have a favorable safety profile. Additionally, Dendreon develops therapeutic vaccines that stimulate the body's immune system to help fight cancer by targeting dendritic cells, which initiate an immune response to disease-causing antigens. The company also develops vaccines to treat breast, colorectal, lung, ovarian and uterine cancers along with monoclonal antibodies to fight blood cancers, such as non-Hodgkin's and B-cell lymphomas. Its partners include Japan's Kirin Brewery and Genentech. Dendreon Corporation is located in Seattle.